Development and validation of an asthma exacerbation prediction model using electronic health record (EHR) data

J Asthma. 2020 Dec;57(12):1339-1346. doi: 10.1080/02770903.2019.1648505. Epub 2019 Aug 8.

Abstract

Objective: Asthma exacerbations are associated with significant morbidity, mortality, and cost. Accurately identifying asthma patients at risk for exacerbation is essential. We sought to develop a risk prediction tool based on routinely collected data from electronic health records (EHRs).Methods: From a repository of EHRs data, we extracted structured data for gender, race, ethnicity, smoking status, use of asthma medications, environmental allergy testing BMI status, and Asthma Control Test scores (ACT). A subgroup of this population of patients with asthma that had available prescription fill data was identified, which formed the primary population for analysis. Asthma exacerbation was defined as asthma-related hospitalization, urgent/emergent visit or oral steroid use over a 12-month period. Univariable and multivariable statistical analysis was completed to identify factors associated with exacerbation. We developed and tested a risk prediction model based on the multivariable analysis.Results: We identified 37,675 patients with asthma. Of those, 1,787 patients with asthma and fill data were identified, and 979 (54.8%) of them experienced an exacerbation. In the multivariable analysis, smoking (OR = 1.69, CI: 1.08-2.64), allergy testing (OR = 2.40, CI: 1.54-3.73), obesity (OR = 1.66, CI: 1.29-2.12), and ACT score reflecting uncontrolled asthma (OR = 1.66, CI: 1.10-2.29) were associated with increased risk of exacerbation. The area-under-the-curve (AUC) of our model in a combined derivation and validation cohort was 0.67.Conclusion: Despite use of rigorous methodology, we were unable to produce a predictive model with an acceptable degree of accuracy and AUC to be clinically useful.

Keywords: Asthma; asthma exacerbation; electronic health records; prediction models.

Publication types

  • Validation Study

MeSH terms

  • Administration, Inhalation
  • Administration, Oral
  • Adult
  • Anti-Asthmatic Agents / administration & dosage*
  • Asthma / diagnosis*
  • Asthma / drug therapy
  • Electronic Health Records / statistics & numerical data
  • Female
  • Forced Expiratory Volume
  • Glucocorticoids / administration & dosage
  • Hospitalization / statistics & numerical data*
  • Humans
  • Hypersensitivity / epidemiology
  • Logistic Models
  • Male
  • Obesity / epidemiology
  • ROC Curve
  • Risk Assessment / methods
  • Risk Factors
  • Severity of Illness Index
  • Smoking / epidemiology
  • Surveys and Questionnaires
  • Symptom Flare Up*

Substances

  • Anti-Asthmatic Agents
  • Glucocorticoids